“…Antibodies against cyclin D1, cyclin E, cyclin A, p21, p27, p53, and -actin were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA Cell Culture. Human umbilical vein endothelial cells (HUVECs) and human aortic endothelial cells (HAECs) were purchased from Lonza Incorporated (Allendale, NJ) and subcultured on gelatincoated dishes as described previously (Wei et al, 2009). Cells were grown in M199 medium supplemented with 20% bovine calf serum, 2 mM L-glutamine, 50 g/ml endothelial cell growth factor, 90 g/ml heparin, and 100 U/ml of penicillin and streptomycin at 37°C in a humidified 95% air-5% CO 2 atmosphere.…”